^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

LB1909

i
Other names: LB1909, dual specificity CD19 and CD22 CAR-T cell immunotherapy, LCAR-L10D
Associations
Company:
Legend Biotech
Drug class:
CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
Associations